Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells

Immunology Letters

Volumn 95, Issue 1, 2004, Pages 109-112

  Marroquin, Carlos E ^a   Downey, Laura ^a   Guo, Hongtao ^a   Kuo, Paul C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Extracellular matrix; Hyaluronate; Metastasis

Indexed keywords

ANISOMYCIN; CRYSTAL VIOLET; HERMES ANTIGEN; HYALURONIC ACID; LIGAND; MESSENGER RNA; OSTEOPONTIN; PROTEIN SYNTHESIS INHIBITOR; VITRONECTIN RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL ASSAY; CELL MEMBRANE; CELL MIGRATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HALF LIFE TIME; LEUKEMIA CELL; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; UPREGULATION;

ANIMALS; ANISOMYCIN; ANTIGENS, CD44; CELL ADHESION; CELL LINE, TUMOR; LEUKEMIA; MICE; NEOPLASMS, EXPERIMENTAL; OLIGOPEPTIDES; OSTEOPONTIN; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 4344561931     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.06.001     Document Type: Article

References (13)

1. Senger D.R., Perruzzi C.A., Papadopoulos-Sergiou A., Van de Water L. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell. 5:1994;565-574
2. Craig A.M., Denhardt D.T. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene. 100:1991;163-171
3. Denhardt D.T., Lopez C.A., Rollo E.E., Hwang S.M., An X.R., Walther S.E. Osteopontin-induced modifications of cellular functions. Ann NY Acad Sci. 760:1995;127-142
4. Weber G.F. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta. 1552:2001;61-85
5. Gao C., Guo H., Downey L., Marroquin C., Wei J., Kuo P.C. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis. 24:2003;1871-1878
6. Yohko U.K., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., Chikuma S., Yagita H., Okumura K., Murakami M., Saiki I., Chambers A.F., Uede T. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59:1999;219-226
7. Angelucci A., Festuccia C., D'Andrea G., Teti A., Bologna M. Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators. Biol Chem. 383:2002;229-234
8. Furger K.A., Allan A.L., Wilson S.M., Hota C., Vantyghem S.A., Postenka C.O., Al-Katib W., Chambers A.F., Tuck A.B. β3-integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin. Mol Cancer Res. 1:2003;810-819
9. 3 integrin, osteopontin, and thrombin. Am J Pathol. 149:1996;293-305
10. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Mol Pathol. 5:1999;189-196
11. Rudzki Z., Jothy S. CD44 and the adhesion of neoplastic cells. Mol Pathol. 50:1997;57-71
12. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24
13. Singhal H., Bautista D.S., Tonkin K.S., O'Malley F.P., Tuck A.B., Chambers A.F., Harris J.F. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res. 3:1997;605-611